Adam Mierzwa
Neurology · Toledo, OHNPI 1811525272
Payments from drug & device makers
Across 62 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$244
- Penumbra, Inc.$178
- Neurelis, Inc.$175
- Amgen$145
- SK Life Science, Inc.$84
- Stryker$67
- plus $499 from 17 others
What the payments were for
- Food & beverage$1,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 15 | $244 |
| Penumbra, Inc. | 3 | $178 |
| Neurelis, Inc. | 7 | $175 |
| Amgen | 4 | $145 |
| SK Life Science, Inc. | 5 | $84 |
| Stryker | 1 | $67 |
| Argenx US, Inc. | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 1 | $58 |
| AbbVie | 3 | $58 |
| Pfizer | 3 | $47 |
| Acadia Pharmaceuticals Inc | 3 | $45 |
| AstraZeneca | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Catalyst Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| CSL Behring | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,391 in reported general payments places this provider in the 45th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EprontiaTopiramate | 11 | $7,787 |
| Lacosamide | 26 | $1,916 |
| Levetiracetam | 26 | $726 |
| Memantine Hcl | 15 | $596 |
| Valproic AcidValproic Acid (As Sodium Salt) | 11 | $536 |
| Lamotrigine | 47 | $326 |
| Topiramate | 14 | $322 |
| Phenobarbital | 12 | $244 |
| Donepezil Hcl | 18 | $212 |
| Gabapentin | 14 | $210 |
| Methylprednisolone | 12 | $83 |
| Prednisone | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other neurology in Toledo
- Lawrence ElmerToledo$1.5M
- Mouhammad JumaaToledo$1.1M
- Howard SchechtToledo$564K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
- Robert BermelCleveland$6.4M
- Aaron BosterColumbus$6.3M
- Ryan DrakeCanton$5.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.